Skip to main content
Caplight Logo









Spatomics

Spatomics

Private
Guilford, ConnecticutHealthcare & Life Scienceshttps://www.spatomics.com/

Last Round

Accelerator

Nov 9, 2023

Total Funding Raised

$25,000

Company Overview

Spatomics is a biotechnology company that develops spatial biology research tools, including patented Cleavable Fluorescent Probe (CFP™) technology for high-plex biomarker profiling in tissue samples.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

spatial biologyspatial transcriptomicssingle-cell analysisbioinformaticscontract research organizationCROgene expression mappingcellular profilingtissue analysisspatial proteomicslab automationcleavable fluorescent probeCFPprecision medicineomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spatomics Comparables

Compare Spatomics with similar companies based on industry and business-model similarity.

Spatomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Resolve Biosciences
83%
Vizgen
81%
Stellaromics
80%

Spatomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 9, 2023

Key People

Founding team and executive leadership

Rui Zheng

Founder, CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 361% MoM, from 309 to 1.4K.

  • Nov 9, 2023

    $25K round from Skysong Innovations

Spatomics Filings

Explore SEC and related filing metadata, where available.

Spatomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spatomics's valuation, stock price, and market status.

Is Spatomics a public or private company?

Spatomics is a private company.

What is the current stock price of Spatomics?

Spatomics is a private company with no public stock price. No recent secondary market data is available.

How much is Spatomics worth (valuation)?

Valuation information for Spatomics is not publicly available.

Can I buy Spatomics stock?

Spatomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spatomics's last funding round?

Spatomics's most recent funding round was Accelerator on November 9, 2023.

Who are the main investors in Spatomics?

Investor information for Spatomics is not publicly disclosed.

Will Spatomics IPO soon?

No public IPO plans have been announced for Spatomics.

How can I track Spatomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spatomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGuilford, Connecticut
Employee Range7
Year Founded2023
Last FundingNov 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?